The New Yorker Radio Hour cover image

Jia Tolentino on the Ozempic Weight-Loss Craze

The New Yorker Radio Hour

00:00

Introduction

Ozempic was first approved in 2017 as a treatment for type 2 diabetes. Staff writer, Geotone Tino, has been reporting on the use and misuse of Ozempic. And what it says about our relationships to our bodies today.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app